Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis

Connick, P; De Angelis, F; Parker, RA; Plantone, D; Doshi, A; John, N; Stutters, J; ... UK Multiple Sclerosis Society Clinical Trials Network, ; + view all Connick, P; De Angelis, F; Parker, RA; Plantone, D; Doshi, A; John, N; Stutters, J; MacManus, D; Prados Carrasco, F; Barkhof, F; Ourselin, S; Braisher, M; Ross, M; Cranswick, G; Pavitt, SH; Giovannoni, G; Gandini Wheeler-Kingshott, CA; Hawkins, C; Sharrack, B; Bastow, R; Weir, CJ; Stallard, N; Chandran, S; Chataway, J; UK Multiple Sclerosis Society Clinical Trials Network, ; - view fewer (2018) Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis. BMJ Open , 8 , Article e021944. 10.1136/bmjopen-2018-021944 . Green open access

https://ift.tt/2xr6xus